2-Amino-5-aryl-pyridines as selective CB2 agonists: Synthesis and investigation of structure–activity relationships
摘要:
2-Amino-5-aryl-pyridines, exemplified by compound 1, had been identified as a synthetically tractable series of CB2 agonists from a high-throughput screen of the GlaxoSmithKline compound collection. Described herein are the results of an investigation of the structure-activity relationships (SAR) which led to the identification a number of potent and selective agonists. (C) 2009 Elsevier Ltd. All rights reserved.
Wright; Hageman; McClure, Journal of Heterocyclic Chemistry, 1998, vol. 35, # 3, p. 717 - 723
作者:Wright、Hageman、McClure
DOI:——
日期:——
[EN] PLANT GROWTH REGULATING COMPOUNDS<br/>[FR] COMPOSÉS RÉGULANT LA CROISSANCE DES PLANTES
申请人:SYNGENTA PARTICIPATIONS AG
公开号:WO2014131732A2
公开(公告)日:2014-09-04
The present invention relates to novel non-steroidal brassinosteroid mimetic derivatives, to processes and intermediates for preparing them, to plant growth regulator compositions comprising them and to methods of using them for controlling the growth of plants and/or promoting the germination of seeds.
[EN] PLANT GROWTH REGULATING COMPOUNDS<br/>[FR] COMPOSÉS RÉGULATEURS DE CROISSANCE DES PLANTES
申请人:SYNGENTA PARTICIPATIONS AG
公开号:WO2013164245A1
公开(公告)日:2013-11-07
The present invention relates to novel non-steroidal brassinosteroid mimetic derivatives, to processes and intermediates for preparing them, to plant growth regulator compositions comprising them and to methods of using them for controlling the growth of plants and/or promoting the germination of seeds.
2-Amino-5-aryl-pyridines as selective CB2 agonists: Synthesis and investigation of structure–activity relationships
作者:Robert J. Gleave、Paul J. Beswick、Andrew J. Brown、Gerard M.P. Giblin、Carl P. Haslam、David Livermore、Andrew Moses、Neville H. Nicholson、Lee W. Page、Brian Slingsby、Martin E. Swarbrick
DOI:10.1016/j.bmcl.2009.10.041
日期:2009.12
2-Amino-5-aryl-pyridines, exemplified by compound 1, had been identified as a synthetically tractable series of CB2 agonists from a high-throughput screen of the GlaxoSmithKline compound collection. Described herein are the results of an investigation of the structure-activity relationships (SAR) which led to the identification a number of potent and selective agonists. (C) 2009 Elsevier Ltd. All rights reserved.